Skip to main content
SpringerLink
Log in

Critical Care Management of Guillain-Barré Syndrome

  • Chapter
  • First Online:
Book cover Textbook of Neuroanesthesia and Neurocritical Care

  • 1407 Accesses

Abstract

Guillain-Barré syndrome (GBS), also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP), is an inflammatory disorder affecting the peripheral nervous system that is characterized by acute or subacute onset and typically monophasic course of the disease. Some patients with this disorder need hospitalization in an intensive care unit (ICU). Among neuromuscular disorders, only several ones require monitoring and treatment at ICUs, namely, GBS, amyotrophic lateral sclerosis, and acute myasthenia gravis. Management of these patients in ICU normally includes specific therapy, vital signs’ monitoring, treatment of systemic complications, as well as the elimination of autonomic nervous system disorders.

GBS is considered the most common cause of inflammatory polyneuropathies, the annual frequency of which is estimated as 1–3 cases per 100,000 people.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wijdicks E. Management of acute neuromuscular disorders. Critical Care Neurology Part I. Handb Clin Neurol. 2017;140:229–37.

    Article  CAS  PubMed  Google Scholar 

  2. Burns T, Lawn N, Low P, Camilleri M, Wijdicks E. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve. 2001;24(7):963–5.

    Article  CAS  PubMed  Google Scholar 

  3. Greenland P. Arrhythmic complications in the Guillain-Barre syndrome. Arch Intern Med. 1980;140(8):1053.

    Article  CAS  PubMed  Google Scholar 

  4. Henderson R, Lawn N, Fletcher D, McClelland R, Wijdicks E. The morbidity of Guillain-Barre syndrome admitted to the intensive care unit. Neurology. 2003;60(1):17–21.

    Article  CAS  PubMed  Google Scholar 

  5. Meena A, Murthy J, Khadilkar S. Treatment guidelines for Guillain-Barre syndrome. Ann Indian Acad Neurol. 2011;14(5):73.

    Article  Google Scholar 

  6. McGrogan A, Madle G, Seaman H, de Vries C. The epidemiology of Guillain-Barre syndrome worldwide. Neuroepidemiology. 2008;32(2):150–63.

    Article  PubMed  Google Scholar 

  7. Sejvar J, Baughman A, Wise M, Morgan O. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.

    Article  PubMed  Google Scholar 

  8. Jacobs B, Rothbarth P, van der Meche F, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51(4):1110–5.

    Article  CAS  PubMed  Google Scholar 

  9. Mori M. Haemophilus influenzae infection and Guillain-Barre syndrome. Brain. 2000;123(10):2171–8.

    Article  PubMed  Google Scholar 

  10. Zhang M, Gilbert M, Yuki N, et al. Association of anti-GT1a antibodies with an outbreak of Guillain-Barre syndrome and analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain. PLoS One. 2015;10(7):e0131730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Broutet N, Krauer F, Riesen M, et al. Zika virus as a cause of neurological disorders. N Engl J Med. 2016;374(16):1506–9.

    Article  CAS  PubMed  Google Scholar 

  12. van Der Meché FG, van Doorn P. Guillain-Barre syndrome. Curr Treat Options Neurol. 2000;2(6):507–16.

    Article  Google Scholar 

  13. Hadden R, Karch H, Hartung H, et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology. 2001;56(6):758–65.

    Article  CAS  PubMed  Google Scholar 

  14. van Doorn P, Ruts L, Jacobs B. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 2008;7(10):939–50.

    Article  PubMed  Google Scholar 

  15. Kwong J, Vasa P, Campitelli M, et al. Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013;13(9):769–76.

    Article  CAS  PubMed  Google Scholar 

  16. Rees J, Soudain S, Gregson N, Hughes R. Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med. 1995;333(21):1374–9.

    Article  CAS  PubMed  Google Scholar 

  17. Ledeen RW, Yu RK. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 1982;83:139–91.

    Article  CAS  PubMed  Google Scholar 

  18. Ho T, Willison H, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol. 1999;45(2):168–73.

    Article  CAS  PubMed  Google Scholar 

  19. Jacobs B, van Doorn P, Tio-Gillen A, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol. 1996;40(2):181–7.

    Article  CAS  PubMed  Google Scholar 

  20. Willison H, Jacobs B, van Doorn P. Guillain-Barre syndrome. Lancet. 2016;388(10045):717–27.

    Article  PubMed  Google Scholar 

  21. Asthana P, Vong J, Kumar G, et al. Dissecting the role of anti-ganglioside antibodies in Guillain-Barre syndrome: an animal model approach. Mol Neurobiol. 2015;53(7):4981–91.

    Article  CAS  PubMed  Google Scholar 

  22. Hughes R, Cornblath D. Guillain-Barre syndrome. Lancet. 2005;366(9497):1653–66.

    Article  CAS  PubMed  Google Scholar 

  23. Landry O. Note sur la paralysis ascendant ague. Gaz Hebd Med Chir. 1859;6:472–88.

    Google Scholar 

  24. Guillan G, Barré JA, Strohl A. Sur un syndrome de radiculo-névrite avec hyperalbuminose du liquid cephalorachidien sans réaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux. Bull Soc Méd Hôp Paris. 1916;40:1462–70.

    Google Scholar 

  25. Draganescu S, Claudian J. Sur un cas de radiculo-névrite curable (syndrome de Guillain-Barré) apparue au cours d'une osteomyelite du bras. Rev Neurol. 1927;2:517–9.

    Google Scholar 

  26. Osler L, Sidell A. The Guillain-Barre syndrome. N Engl J Med. 1960;262(19):964–9.

    Article  CAS  PubMed  Google Scholar 

  27. Criteria for diagnosis of Guillain-Barre syndrome. Ann Neurol. 1978;3:565–6.

    Google Scholar 

  28. Asbury A, Cornblath D. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol. 1990;27(S1):S21–4.

    Article  PubMed  Google Scholar 

  29. Kusunoki S. History of Guillain-Barre syndrome. Clin Exp Neuroimmunol. 2016;7(4):305–11.

    Article  Google Scholar 

  30. Sejvar J, Kohl K, Gidudu J, et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599–612.

    Article  PubMed  Google Scholar 

  31. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn P, Jacobs B. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2013;137(1):33–43.

    Article  PubMed  Google Scholar 

  32. Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barre and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014;10(9):537–44.

    Article  PubMed  Google Scholar 

  33. Wakerley B, Kokubun N, Funakoshi K, Nagashima T, Hirata K, Yuki N. Clinical classification of 103 Japanese patients with Guillain-Barre syndrome. J Neurol Sci. 2016;369:43–7.

    Article  PubMed  Google Scholar 

  34. Hiew F, Ramlan R, Viswanathan S, Puvanarajah S. Guillain-Barre syndrome, variants & forms fruste: reclassification with new criteria. Clin Neurol Neurosurg. 2017;158:114–8.

    Article  PubMed  Google Scholar 

  35. Feasby T, Gilbert J, Brown W, et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain. 1986;109(6):1115–26.

    Article  PubMed  Google Scholar 

  36. Griffin J, Li C, Ho T, et al. Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann Neurol. 1996;39(1):17–28.

    Article  CAS  PubMed  Google Scholar 

  37. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255(2):57–65.

    Article  CAS  PubMed  Google Scholar 

  38. Overell J, Willison H. Recent developments in Miller Fisher syndrome and related disorders. Curr Opin Neurol. 2005;18(5):562–6.

    Article  CAS  PubMed  Google Scholar 

  39. Odaka M, Yuki N, Yamada M, et al. Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome. Brain. 2003;126(10):2279–90.

    Article  PubMed  Google Scholar 

  40. Kashihara K, Shiro Y, Koga M, Yuki N. IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 1998;65(5):799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Wakerley B, Yuki N. Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2013;85(3):339–44.

    Article  PubMed  Google Scholar 

  42. Koike H, Atsuta N, Adachi H, et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain. 2010;133(10):2881–96.

    Article  PubMed  Google Scholar 

  43. Ohyama K, Koike H, Masuda M, et al. Autonomic manifestations in acute sensory ataxic neuropathy: a case report. Auton Neurosci. 2013;179(1–2):155–8.

    Article  PubMed  Google Scholar 

  44. van Doorn P. Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS). Presse Med. 2013;42(6):e193–201.

    Article  PubMed  Google Scholar 

  45. Yuki N, Kokubun N, Kuwabara S, et al. Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes. J Neurol. 2011;259(6):1181–90.

    Article  PubMed  Google Scholar 

  46. Moulin D, Hagen N, Feasby T, Amireh R, Hahn A. Pain in Guillain-Barre syndrome. Neurology. 1997;48(2):328–31.

    Article  CAS  PubMed  Google Scholar 

  47. Hughes R, Swan A, van Doorn P. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;9:CD002063. https://doi.org/10.1002/14651858.cd002063.pub6.

    Article  Google Scholar 

  48. Lawn N, Fletcher D, Henderson R, Wolter T, Wijdicks E. Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):893.

    Article  CAS  PubMed  Google Scholar 

  49. Gupta S, Taly A, Suresh T, Rao S, Nagaraja D. Acute idiopathic axonal neuropathy (AIAN): a clinical and electrophysiological observation. Acta Neurol Scand. 2009;89(3):220–4.

    Article  Google Scholar 

  50. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs B, van Doorn P. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.

    Article  CAS  PubMed  Google Scholar 

  51. Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes. J Neurol Neurosurg Psychiatry. 2010;81(10):1157–63.

    Article  PubMed  Google Scholar 

  52. Hadden R, Cornblath D, Hughes R, et al. Electrophysiological classification of guillain-Barre syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5):780–8.

    Article  CAS  PubMed  Google Scholar 

  53. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123(8):1487–95.

    Article  PubMed  Google Scholar 

  54. Evans O. Guillain-Barre syndrome in children. Pediatr Rev. 1986;8(3):69–74.

    Article  CAS  PubMed  Google Scholar 

  55. Jones H. Topical review: childhood Guillain-Barre syndrome: clinical presentation, diagnosis, and therapy. J Child Neurol. 1996;11(1):4–12.

    Article  CAS  PubMed  Google Scholar 

  56. Yuki N, Hartung H. Guillain-Barre syndrome. N Engl J Med. 2012;366(24):2294–304.

    Article  CAS  PubMed  Google Scholar 

  57. Sharshar T, Chevret S, Bourdain F, Raphaël JC. Early predictors of mechanical ventilation in Guillain-Barre syndrome. Crit Care Med. 2003;31(1):278–83.

    Article  PubMed  Google Scholar 

  58. Sundar U, Abraham E, Gharat A, Yeolekar ME, Trivedi T, Dwivedi N. Neuromuscular respiratory failure in Guillain-Barré Syndrome: evaluation of clinical and electrodiagnostic predictors. J Assoc Physicians India. 2005;53:764–8.

    PubMed  Google Scholar 

  59. Durand M, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021–8.

    Article  PubMed  Google Scholar 

  60. Fourrier F, Robriquet L, Hurtevent J, Spagnolo S. A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barre syndrome. Crit Care. 2011;15(1):R65.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Rumbak M, Newton M, Truncale T, Schwartz S, Adams J, Hazard P. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med. 2004;32(8):1689–94.

    Article  PubMed  Google Scholar 

  62. Dhar R, Stitt L, Hahn A. The morbidity and outcome of patients with Guillain-Barre syndrome admitted to the intensive care unit. J Neurol Sci. 2008;264(1–2):121–8.

    Article  PubMed  Google Scholar 

  63. Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael J, Clair B. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barre syndrome. Intensive Care Med. 2006;32(12):1962–9.

    Article  PubMed  Google Scholar 

  64. Hiraga A, Mori M, Ogawara K, Hattori T, Kuwabara S. Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes. Neurology. 2003;61(4):471–4.

    Article  CAS  PubMed  Google Scholar 

  65. Walgaard C, Lingsma H, Ruts L, et al. Prediction of respiratory insufficiency in Guillain-Barre syndrome. Ann Neurol. 2010;67(6):781–7.

    PubMed  Google Scholar 

  66. Bhagat H, Dash H, Chauhan R, Khanna P, Bithal P. Intensive care management of Guillain-Barre syndrome: a retrospective outcome study and review of literature. J Neuroanaesth Crit Care. 2014;1(3):188.

    Article  Google Scholar 

  67. Elovaara I, Apostolski S, van Doorn P, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008;15(9):893–908.

    Article  CAS  PubMed  Google Scholar 

  68. Patwa H, Chaudhry V, Katzberg H, Rae-Grant A, So Y. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78(13):1009–15.

    Article  CAS  PubMed  Google Scholar 

  69. Brettle R, Gross M, Legg N, Lockwood M, Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet. 1978;312(8099):1100.

    Article  Google Scholar 

  70. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development. JAMA. 1986;256(10):1333–7.

    Google Scholar 

  71. Kleyweg R, van der Meche F, Meulstee J. Treatment of Guillain-Barre syndrome with high-dose gamma globulin. Neurology. 1988;38(10):1639.

    Article  CAS  PubMed  Google Scholar 

  72. van der Meché F, Schmitz P. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N Engl J Med. 1992;326(17):1123–9.

    Article  PubMed  Google Scholar 

  73. Ruts L, van Koningsveld R, van Doorn P. Distinguishing acute-onset CIDP from Guillain-Barre syndrome with treatment related fluctuations. Neurology. 2005;65(1):138–40.

    Article  PubMed  Google Scholar 

  74. Hughes R, Swan A, Raphael J, Annane D, van Koningsveld R, van Doorn P. Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain. 2007;130(9):2245–57.

    Article  PubMed  Google Scholar 

  75. Dionne A, Nicolle M, Hahn A. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010;41(2):202–7.

    PubMed  Google Scholar 

  76. Pritchard J, Hughes R, Hadden R, Brassington R. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2016;11:CD008630.

    PubMed  Google Scholar 

  77. Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2006;2:CD001446.

    Google Scholar 

  78. Plasmapheresis and acute Guillain-Barre syndrome. Neurology. 1985;35(8):1096.

    Google Scholar 

  79. Hughes RAC, Swan AV, for Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet. 1997;349:225–30.

    Article  Google Scholar 

  80. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barre syndrome. Transfus Med Rev. 1996;10(4):316–7.

    Google Scholar 

  81. Nomura T, Hamaguchi K, Hattori T, et al. A randomized controlled trial comparing intravenous immunoglobulin and plasmapheresis in Guillain-Barré syndrome. Neurol Ther. 2000;18:69–81.

    Google Scholar 

  82. Diener H, Haupt W, Kloss T, et al. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barre syndrome. Eur Neurol. 2001;46(2):107–9.

    Article  CAS  PubMed  Google Scholar 

  83. van Koningsveld R, Schmitz P, van der Meché F, Visser L, Meulstee J, van Doorn P. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet. 2004;363(9404):192–6.

    Article  CAS  PubMed  Google Scholar 

  84. Raphael J. Intravenous immune globulins in patients with Guillain-Barre syndrome and contraindications to plasma exchange: 3 days versus 6 days. J Neurol Neurosurg Psychiatry. 2001;71(2):235–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Ruts L, Drenthen J, Jacobs B, van Doorn P. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010;74(21):1680–6.

    Article  CAS  PubMed  Google Scholar 

  86. Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2017;2:CD001798.

    PubMed  Google Scholar 

  87. Prevots D, Sutter R. Assessment of Guillain-Barre syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis. 1997;175(Suppl 1):S151–5.

    Article  PubMed  Google Scholar 

  88. Raphael JC, Masson C, Morice V, Bronel D, Goulon M. Le syndrome de Guillain-Barré: étude retrospective de 233 observations. Sem Hôpitaux Paris. 1984;60:2543–6.

    Google Scholar 

  89. Rees J, Thompson R, Smeeton N, Hughes R. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64(1):74–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients. Brain. 1996;119(6):2053–61.

    Google Scholar 

  91. Fletcher D, Lawn N, Wolter T, Wijdicks E. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology. 2000;54(12):2311–5.

    Article  CAS  PubMed  Google Scholar 

  92. Winer J, Hughes R, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988;51(5):605–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Delaney A, Bagshaw SM, Nalos M. Percutaneous dilatational tracheostomy versus surgical tracheostomy in critically ill patients: a systematic review and meta-analysis. Crit Care. 2006;18(6):544.

    Google Scholar 

  94. McCredie V, Alali A, Scales D, et al. Effect of early versus late tracheostomy or prolonged intubation in critically ill patients with acute brain injury: a systematic review and meta-analysis. Neurocrit Care. 2016;26(1):14–25.

    Article  Google Scholar 

  95. Dempsey G, Morton B, Hammell C, Williams L, Tudur Smith C, Jones T. Long-term outcome following tracheostomy in critical care. Crit Care Med. 2016;44(3):617–28.

    Article  PubMed  Google Scholar 

  96. Andriolo B, Andriolo R, Saconato H, Atallah ÁN, Valente O, Valente O. Early versus late tracheostomy for critically ill patients. Cochrane Database Syst Rev. 2015;1:CD007271. https://doi.org/10.1002/14651858.cd007271.pub3.

    Article  PubMed  Google Scholar 

  97. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barre syndrome. Am J Med. 1971;50(6):772–80.

    Article  CAS  PubMed  Google Scholar 

  98. Singh N, Jaiswal A, Misra S, Srivastava P. Assessment of autonomic dysfunction in Guillain-Barre syndrome and its prognostic implications. Acta Neurol Scand. 1987;75(2):101–5.

    Article  CAS  PubMed  Google Scholar 

  99. Emmons P, Blume W, DuShane J. Cardiac monitoring and demand pacemaker in Guillain-Barre syndrome. Arch Neurol. 1975;32(1):59–61.

    Article  CAS  PubMed  Google Scholar 

  100. Patel M, Goyal S, Punnam S, Pandya K, Khetarpal V, Thakur R. Guillain-Barre syndrome with asystole requiring permanent pacemaker: a case report. J Med Case Rep. 2009;3(1):5.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013;31(2):491–510.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Hughes R, Wijdicks E, Benson E, et al. Supportive care for patients with Guillain-Barre syndrome. Arch Neurol. 2005;62(8):1194.

    Article  PubMed  Google Scholar 

  103. Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, Miller DH. Management and outcome of severe Guillain-Barre syndrome. QJM. 1995;88(4):243–50. https://doi.org/10.1093/oxfordjournals.qjmed.a069055.

    Article  CAS  PubMed  Google Scholar 

  104. Rajabally YA, Uncini A. Outcome and its predictors in Guillain Barre syndrome. J Neurol Neurosurg Psychiatry. 2012;83:711–8.

    Article  PubMed  Google Scholar 

  105. Lawn N, Wijdicks E. Fatal Guillain-Barre syndrome. Neurology. 1999;52(3):635.

    Article  CAS  PubMed  Google Scholar 

  106. Taly AB, Gupta SK, Vasanth A, Suresh TG, Rao U, Nagaraja D, Swamy HS, Rao S, Subbakrishna DKJ. Critically ill Guillain Barre’ syndrome. J Assoc Physicians India. 1994;42(11):871–4.

    CAS  PubMed  Google Scholar 

  107. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70(18):1608–13.

    Article  PubMed  Google Scholar 

  108. Hughes R. The Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome: a multicentre prospective study of 297 patients. Brain. 1998;121(4):767–9.

    Article  PubMed  Google Scholar 

  109. Koeppen S, Kraywinkel K, Wessendorf T, et al. Long-term outcome of Guillain-Barre syndrome. Neurocrit Care. 2006;5(3):235–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Burnazian State Research Center, Federal and Biological Agency of Russia, Moscow, Russia

    Ekaterina V. Bril

  2. Department of Anesthesia and Intensive Care, Burnazian State Research Center, Federal and Biological Agency of Russia, Moscow, Russia

    Konstantin A. Popugaev

  3. Sklifosovsky Research Institute of Emergency Medicine, Moscow, Russia

    Konstantin A. Popugaev

  4. Burnazian State Research Center of Federal and Biological Agency of Russia, Moscow, Russia

    Yuriy D. Udalov, Oleg V. Parinov, Maxim V. Zabelin & Alexandr S. Samoilov

Authors
  1. Ekaterina V. Bril
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Konstantin A. Popugaev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuriy D. Udalov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oleg V. Parinov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maxim V. Zabelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexandr S. Samoilov
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India

    Hemanshu Prabhakar

  2. Division of Neuroanesthesiology, Department of Anesthesiology, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India

    Zulfiqar Ali

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bril, E.V., Popugaev, K.A., Udalov, Y.D., Parinov, O.V., Zabelin, M.V., Samoilov, A.S. (2019). Critical Care Management of Guillain-Barré Syndrome. In: Prabhakar, H., Ali, Z. (eds) Textbook of Neuroanesthesia and Neurocritical Care. Springer, Singapore. https://doi.org/10.1007/978-981-13-3390-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3390-3_4

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3389-7

  • Online ISBN: 978-981-13-3390-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation